2023 Current opinion in ophthalmol…

Novel approach to Behcet's disease in the era of biologic agents.

,

Current opinion in ophthalmology Vol. 34 (6) : 535-542 • Nov 2023

PURPOSE: This review aims to provide better understanding of modern modalities to investigate ocular symptoms of Behcet's disease in order to achieve appropriate management protocols and reduce irreversible visual loss. RELEVANT FINDINGS: Current methods of diagnosing intraocular involvement in Behcet's disease gives clue to early diagnosis. In addition to standard ocular examination and fluorescein angiography, new noninvasive methods include ocular coherence tomography (OCT) and OCT angiography provide early detection of macular and retinal involvement that can be treated early to improve the prognosis. SUMMARY: Over the last decade, new multimodal imagings are becoming more accessible; therefore, rapid diagnosis can be made. In addition to newer approved biologic agents, ocular Behcet's disease is seen to be in better controlled with fewer complications.

No clinical trial protocols linked to this paper

Clinical trials are automatically linked when NCT numbers are found in the paper's title or abstract.
PICO Elements

No PICO elements extracted yet. Click "Extract PICO" to analyze this paper.

Paper Details
MeSH Terms
Associated Data

No associated datasets or code repositories found for this paper.

Related Papers

Related paper suggestions will be available in future updates.